Terms: = Leukemia AND DNMT3A, Q9Y6K1, 1788, ENSG00000119772, DNMT3A2, M_HsaIIIA AND Prognosis
303 results:
1. Prognostic impact of clonal hematopoiesis mutations at complete molecular remission in acute myeloid leukemia with NPM1 mutation.
Wang L; Shu M; Zhang Z; Dou X; Xu X; Ma Y; Wen L; Yang X; Chen S
J Cancer Res Clin Oncol; 2024 Oct; 150(10):465. PubMed ID: 39422784
[TBL] [Abstract] [Full Text] [Related]
2. [CLAG±DAC regimen in the treatment of refractory/relapsed acute myeloid leukemia].
Hua WX; Yao WQ; Zhou M; Qi JQ; Kang HZ; Wang RJ; Cai CS; Liu YJ; Wu DP; Han Y
Zhonghua Xue Ye Xue Za Zhi; 2024 Sep; 45(9):838-843. PubMed ID: 39414607
[No Abstract] [Full Text] [Related]
3. [Prognostic Value of DTA Mutations in Patients with Newly Diagnosed Acute Myeloid leukemia].
Chen HJ; Cao Y; Miao YJ; Zhou YF; Liu Y; Gu WY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Aug; 32(4):993-998. PubMed ID: 39192388
[TBL] [Abstract] [Full Text] [Related]
4. Variation characteristics and clinical significance of
Ma Q; Liu Y; Zhao H; Guo Y; Sun W; Hu R
Hematology; 2024 Dec; 29(1):2387878. PubMed ID: 39140716
[No Abstract] [Full Text] [Related]
5. Influence of genetic co-mutation on chemotherapeutic outcome in NPM1-mutated and FLT3-ITD wild-type AML patients.
Wu Q; Zhang Y; Yuan B; Huang Y; Jiang L; Liu F; Yan P; Cheng J; Long Z; Jiang X
Cancer Med; 2024 Aug; 13(15):e70102. PubMed ID: 39126219
[TBL] [Abstract] [Full Text] [Related]
6. Contemporary Management of Acute Myeloid leukemia: A Review.
Venugopal S; Sekeres MA
JAMA Oncol; 2024 Oct; 10(10):1417-1425. PubMed ID: 39115831
[TBL] [Abstract] [Full Text] [Related]
7. Genomic mutation patterns and prognostic value in de novo and secondary acute myeloid leukemia: A multicenter study from China.
Dou X; Dan C; Zhang D; Zhou H; He R; Zhou G; Zhu Y; Fu N; Niu B; Xu S; Liao Y; Luo Z; Yang L; Zhang H; Xu Y; Zhan Q; Chen W; Yang Z; Tang X; Zhang H; Xiao Q; Chen J; Liu L; Wang Y; Pei L; Wang L
Int J Cancer; 2024 Dec; 155(12):2253-2264. PubMed ID: 39109820
[TBL] [Abstract] [Full Text] [Related]
8. The profile and prognostic significance of bone marrow T-cell differentiation subsets in adult AML at diagnosis.
Sun K; Shi ZY; Wang YZ; Xie DH; Liu YR; Jiang Q; Jiang H; Huang XJ; Qin YZ
Front Immunol; 2024; 15():1418792. PubMed ID: 39100667
[TBL] [Abstract] [Full Text] [Related]
9. Clonal Hematopoiesis-Associated Gene Mutations Affect Acute Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation in AML Patients.
Wei X; Huang S; Gu Z; Liu J; Li M; Jin X; Bo J; Li F; Jing Y; Gao X; Dou L; Liu D; Gao C
Ann Transplant; 2024 Jul; 29():e943688. PubMed ID: 38952007
[TBL] [Abstract] [Full Text] [Related]
10. Multi-target measurable residual disease assessed by error-corrected sequencing in patients with acute myeloid leukemia: An ALFA study.
Hirsch P; Lambert J; Bucci M; Deswarte C; Boudry A; Lambert J; Fenwarth L; Micol JB; Terré C; Celli-Lebras K; Thomas X; Dombret H; Duployez N; Preudhomme C; Itzykson R; Delhommeau F
Blood Cancer J; 2024 Jun; 14(1):97. PubMed ID: 38871702
[TBL] [Abstract] [Full Text] [Related]
11. Emerging DNA Methylome Targets in FLT3-ITD-Positive Acute Myeloid leukemia: Combination Therapy with Clinically Approved FLT3 Inhibitors.
Tecik M; Adan A
Curr Treat Options Oncol; 2024 Jun; 25(6):719-751. PubMed ID: 38696033
[TBL] [Abstract] [Full Text] [Related]
12. Molecular, clinical, and therapeutic determinants of outcome in NPM1-mutated AML.
Othman J; Potter N; Ivey A; Tazi Y; Papaemmanuil E; Jovanovic J; Freeman SD; Gilkes A; Gale R; Rapoz-D'Silva T; Runglall M; Kleeman M; Dhami P; Thomas I; Johnson S; Canham J; Cavenagh J; Kottaridis P; Arnold C; Ommen HB; Overgaard UM; Dennis M; Burnett A; Wilhelm-Benartzi C; Huntly B; Russell NH; Dillon R
Blood; 2024 Aug; 144(7):714-728. PubMed ID: 38691678
[TBL] [Abstract] [Full Text] [Related]
13. A Case of Chronic Eosinophilic leukemia with CSF3R-Mutant Clone and Transformed to Secondary Acute Myeloid leukemia.
Wu Y; Yang X
Clin Lab; 2024 Apr; 70(4):. PubMed ID: 38623671
[TBL] [Abstract] [Full Text] [Related]
14. XPO1 inhibition displays anti-leukemia efficacy against dnmt3a-mutant acute myeloid leukemia via downregulating glutathione pathway.
Cai X; Liu Y; Li H; Que Y; Xiao M; Wang Y; Wang X; Li D
Ann Hematol; 2024 Jul; 103(7):2311-2322. PubMed ID: 38519605
[TBL] [Abstract] [Full Text] [Related]
15. Comparison of clinical outcomes of several risk stratification tools in newly diagnosed AML patients: A real-world evidence in our current therapeutic era.
Iat A; Loschi M; Benachour S; Calleja A; Chiche E; Sudaka I; Aquaronne D; Ferrero C; Fenwarth L; Marceau A; Fournier E; Dadone-Montaudie B; Cluzeau T
Cancer Med; 2024 Mar; 13(6):e7103. PubMed ID: 38506267
[TBL] [Abstract] [Full Text] [Related]
16. [The Correlation of Gene Mutation and Clinical Characteristics in Patients with Myelodysplastic Syndrome and Prognostic Analysis].
Zhang WW; Zhang YL; Ren CC; Wu TK; Liu B
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):176-183. PubMed ID: 38387918
[TBL] [Abstract] [Full Text] [Related]
17. Clinical characteristics and prognosis of acute myeloid leukemia patients with Runt-related transcription factor 1 mutation: A single-center retrospective analysis.
Wang LY; Li Y; Jiang Q; Jiang H; Wang Y; Xu LP; Zhang XH; Liu KY; Tang FF
Hematol Oncol; 2024 Mar; 42(2):e3256. PubMed ID: 38367260
[TBL] [Abstract] [Full Text] [Related]
18. CALCRL knockdown suppresses cancer stemness and chemoresistance in acute myeloid leukemia with FLT3-ITD and DNM3TA-R882 double mutations.
Tang S; Zhu H; Sheng L; Mu Q; Wang Y; Xu K; Zhou M; Xu Z; Wu A; Ouyang G
Drug Dev Res; 2024 Feb; 85(1):e22137. PubMed ID: 38349260
[TBL] [Abstract] [Full Text] [Related]
19. 5-methylcytosine RNA modification regulators-based patterns and features of immune microenvironment in acute myeloid leukemia.
Ding Y; Bajpai AK; Wu F; Lu W; Xu L; Mao J; Li Q; Pan Q; Lu L; Wang X
Aging (Albany NY); 2024 Jan; 16(3):2340-2361. PubMed ID: 38277218
[TBL] [Abstract] [Full Text] [Related]
20. Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management.
Tefferi A; Vannucchi AM; Barbui T
Am J Hematol; 2024 Apr; 99(4):697-718. PubMed ID: 38269572
[TBL] [Abstract] [Full Text] [Related]
[Next]